Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now later-stage tilt small index

Patient Outcomes: later-stage trial registry

2 of 2 indexed Patient Outcomes trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Patient Outcomes: 2 US clinical trials tracked, 2 recruiting.

Patient Outcomes is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Vance Thompson Vision - MT, running 1 of these trials.

Enrollment posture brief

Registry condition patient-outcomes

OPEN 2 | RECR 100% | LATE 1 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Patient Outcomes (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Patient Outcomes

Patient Outcomes lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Patient Outcomes on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Patient Outcomes is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Top Sponsors

Named interventions

Most-linked intervention names on Patient Outcomes records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Topical Prednisolone Drug
1 trials
Dextenza Drug
1 trials
C3PO Other
1 trials

US sites by state

Facility locations filed on Patient Outcomes trials. A trial with sites in several states counts in each.

Oklahoma 1 trials
Montana 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Patient Outcomes page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Patient Outcomes condition card totals 2 registered trials; most-linked intervention Topical Prednisolone; top US site state Oklahoma. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.